David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$582M |
| 3 |
Walmart Inc
WMT
|
+$407M |
| 4 |
Visa
V
|
+$395M |
| 5 |
Johnson & Johnson
JNJ
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Salesforce
CRM
|
+$380M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 5 |
Colgate-Palmolive
CL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.49% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 8% |
| 5 | Industrials | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
OptimizeRx
OPRX
$146M
| $6.89M | 0.01% |
471,232
+286,250
| +155% | +$4.79M |
|
1552
Immunovant
IMVT
$9.07B
| $6.89M | 0.01% |
444,453
+145,983
| +49% | +$2.53M |
|
1553
PUT
W.W. Grainger
GWW
$62.9B
| $6.89M | 0.01% |
+10,000
| New | +$6.38M |
|
|
AIRC
1554
DELISTED
Apartment Income REIT Corp.
AIRC
| $6.89M | 0.01% |
192,330
-181,087
| -48% | -$6.65M |
|
1555
CALL
Fluor
FLR
$6.96B
| $6.87M | 0.01% |
222,400
+122,000
| +122% | +$4.2M |
|
|
KRTX
1556
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.85M | 0.01% |
37,700
+16,200
| +75% | +$3.1M |
|
1557
Wintrust Financial
WTFC
$10.3B
| $6.83M | 0.01% |
93,686
+82,668
| +750% | +$7.07M |
|
|
VTLE
1558
CALL
DELISTED
Vital Energy
VTLE
| $6.83M | 0.01% |
150,000
+121,700
| +430% | +$6.08M |
|
1559
Coherus Oncology
CHRS
$224M
| $6.83M | 0.01% |
998,378
+278,552
| +39% | +$2.16M |
|
1560
PUT
Jabil
JBL
$32.6B
| $6.81M | 0.01% |
77,200
-4,900
| -6% | -$395K |
|
1561
Omeros
OMER
$1.32B
| $6.8M | 0.01% |
1,462,528
-286,189
| -16% | -$1.03M |
|
|
CS
1562
DELISTED
Credit Suisse Group
CS
| $6.78M | 0.01% |
7,622,772
-2,348,878
| -24% | -$6.55M |
|
1563
Enact Holdings
ACT
$6.77B
| $6.78M | 0.01% |
296,615
-5,428
| -2% | -$129K |
|
|
EBIX
1564
DELISTED
Ebix Inc
EBIX
| $6.77M | 0.01% |
513,438
-124,390
| -20% | -$2.16M |
|
|
SNV
1565
DELISTED
Synovus
SNV
| $6.77M | 0.01% |
219,607
+174,761
| +390% | +$6.65M |
|
1566
Takeda Pharmaceutical
TAK
$58.2B
| $6.76M | 0.01% |
+410,414
| New | +$6.54M |
|
1567
Biomea Fusion
BMEA
$124M
| $6.75M | 0.01% |
217,587
+136,594
| +169% | +$1.7M |
|
1568
Cal-Maine
CALM
$3.88B
| $6.74M | 0.01% |
110,740
+97,256
| +721% | +$5.42M |
|
|
SPLK
1569
PUT
DELISTED
Splunk Inc
SPLK
| $6.74M | 0.01% |
70,300
-66,100
| -48% | -$6.34M |
|
|
GLDD
1570
DELISTED
Great Lakes Dredge & Dock
GLDD
| $6.73M | 0.01% |
1,239,025
+61,745
| +5% | +$370K |
|
1571
Etsy
ETSY
$7.5B
| $6.72M | 0.01% |
60,349
+23,434
| +63% | +$2.91M |
|
1572
CALL
Scorpio Tankers
STNG
$3.75B
| $6.72M | 0.01% |
119,300
+46,000
| +63% | +$2.52M |
|
1573
Kodiak Sciences
KOD
$2.47B
| $6.71M | 0.01% |
1,081,700
-83,552
| -7% | -$585K |
|
1574
PUT
Ciena
CIEN
$57.2B
| $6.7M | 0.01% |
127,600
-49,600
| -28% | -$2.48M |
|
1575
Axcelis
ACLS
$3.72B
| $6.7M | 0.01% |
50,289
+35,689
| +244% | +$4.19M |
|
Similar funds
David Shaw's Q1 2023 Portfolio in Review
As of Q1 2023, David Shaw held 5,246 positions worth $93.4B, up 3.2% from $90.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $9.17B in Q1 2023, closing 860 positions and reducing 1,787 holdings. Its most notable exit was SVB Financial Group, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in State Street Utilities Select Sector SPDR ETF worth $99.9M.
- David Shaw's largest Q1 2023 buy was State Street Utilities Select Sector SPDR ETF: 2,950,552 shares worth $99.9M.
- David Shaw added most to Charles Schwab in Q1 2023, an estimated $602M increase.
- David Shaw's biggest Q1 2023 reduction was Microsoft, cutting an estimated $483M.
- David Shaw fully exited SVB Financial Group in Q1 2023, selling an estimated $163M.
- David Shaw's ten largest holdings make up 11% of its $93.4B portfolio in Q1 2023.
- David Shaw opened 431 new positions and closed 860 in Q1 2023.
- David Shaw's portfolio value rose 3.2% quarter-over-quarter to $93.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.